ClinicalTrials.Veeva

Menu
E

Eastern Virginia Medical School | Internal Medicine Glennan Center for Geriatrics and Gerontology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Estradiol
Omalizumab
Tamoxifen
Paclitaxel
Pregabalin
Rocatinlimab
Estrogen
Ulipristal Acetate
cyclophosphamide
OPN-375

Parent organization

This site is a part of Eastern Virginia Medical School

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 137 total trials

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal pol...

Enrolling
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Drug: Standard therapy for INCS
Drug: LY3650150

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo

The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in...

Active, not recruiting
Chronic Rhinosinusitis with Nasal Polyps
Drug: Placebo
Drug: Verekitug (UPB-101)

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical...

Active, not recruiting
Preclinical Alzheimer's Disease
Early Preclinical Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectivene...

Enrolling
Contraception
Device: Ovaprene

The goal of this study is to obtain user feedback while placing and observing the DAISY uterine drain with wall suction. This study defines the obste...

Enrolling
Uterine Bleeding
Cesarean Section Complications
Device: DAISY Uterine Drain

This is a prospective, multi-center interventional study of the GRAIL multi-cancer early detection (MCED) test with return of test results for partic...

Active, not recruiting
Early Detection of Cancer
Cancer
Device: Multi-Cancer Early Detection Test

The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by e...

Enrolling
Sleep Apnea, Obstructive
Device: Genio System

Trial sponsors

Eastern Virginia Medical School (EVMS) logo
C
SWOG Cancer Research Network logo
H
N
Amgen logo
Daré Bioscience logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
Alliance for Clinical Trials in Oncology logo
Bayer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems